The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention

被引:495
|
作者
Liu, Zhenqiu [1 ,2 ,3 ,4 ,5 ]
Jiang, Yanfeng [1 ,2 ,5 ]
Yuan, Huangbo [3 ,4 ]
Fang, Qiwen [3 ,4 ]
Cai, Ning [1 ,2 ,3 ,4 ,5 ]
Suo, Chen [1 ,2 ,3 ,4 ,5 ]
Jin, Li [1 ,2 ,5 ,6 ]
Zhang, Tiejun [3 ,4 ]
Chen, Xingdong [1 ,2 ,5 ,6 ]
机构
[1] Fudan Univ, Sch Life Sci, Key Lab Genet Engn, Shanghai 200438, Peoples R China
[2] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China
[3] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China
[4] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China
[5] Fudan Univ, Taizhou Inst Hlth Sci, Taizhou, Peoples R China
[6] Fudan Univ, Human Phenome Inst, 825 Zhangheng Rd, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Global liver cancer; HBV; HCV; Alcohol consumption; Prevention; HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; ALCOHOL-CONSUMPTION; MORTALITY; PREVALENCE; CIRRHOSIS; EPIDEMIOLOGY; VACCINATION; PROJECTIONS; INFECTIONS;
D O I
10.1016/j.jhep.2018.12.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Liver cancer is a common malignant neoplasm worldwide. The etiologies for liver cancer are diverse and the incidence trends of liver cancer caused by specific etiologies are rarely studied. We therefore aimed to determine the pattern of liver cancer incidence, as well as temporal trends. Methods: We collected detailed information on liver cancer etiology between 1990-2016, derived from the Global Burden of Disease study in 2016. Estimated annual percentage changes (EAPCs) in liver cancer age standardized incidence rate (ASR), by sex, region, and etiology, were calculated to quantify the temporal trends in liver cancer ASR. Results: Globally, incident cases of liver cancer increased 114.0% from 471,000 in 1990 to 1,007,800 in 2016. The overall ASR increased by an average 0.34% (95% CI 0.22%-0.45%) per year in this period. The ASR of liver cancer due to hepatitis B, hepatitis C, and other causes increased between 1990 and 2016. The corresponding EAPCs were 0.22 (95% CI 0.08-0.36), 0.57 (95% CI 0.48-0.66), and 0.51 (95% CI 0.41-0.62), respectively. The ASR of liver cancer due to reported alcohol use remained stable (EAPC = 0.10, 95% CI -0.06-0.25). This increasing pattern was heterogeneous across regions and countries. The most pronounced increases were generally observed in countries with a high socio-demographic index, including the Netherlands, the UK, and the USA. Conclusions: Liver cancer remains a major public health concern globally, though control of hepatitis B and C virus infections has contributed to the decreasing incidence in some regions. We observed an unfavorable trend in countries with a high socio-demographic index, suggesting that current prevention strategies should be reoriented, and much more targeted and specific strategies should be established in some countries to forestall the increase in liver cancer. Lay summary: Liver cancer is a common malignant neoplasm worldwide. The incidence patterns of liver cancer caused by different etiologies varied considerably across the world. In this study, we aim to determine the pattern of liver cancer incidence as well as the temporal trends, thereby facilitating the establishment of more tailored prevention strategies for liver cancer. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:674 / 683
页数:10
相关论文
共 50 条
  • [1] The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management
    Li, Yongzhi
    Ou, Zejin
    Yu, Danfeng
    He, Huan
    Zheng, Liting
    Chen, Jiaqi
    Chen, Caiyun
    Xiong, Hushen
    Chen, Qing
    [J]. BMC CANCER, 2023, 23 (01)
  • [2] The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management
    Yongzhi Li
    Zejin Ou
    Danfeng Yu
    Huan He
    Liting Zheng
    Jiaqi Chen
    Caiyun Chen
    Hushen Xiong
    Qing Chen
    [J]. BMC Cancer, 23
  • [3] Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China
    Liu, Zhenqiu
    Mao, Xianhua
    Jiang, Yanfeng
    Cai, Ning
    Jin, Li
    Zhang, Tiejun
    Chen, Xingdong
    [J]. CANCER MEDICINE, 2019, 8 (12): : 5787 - 5799
  • [4] The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017
    Lin, Longfei
    Yan, Lei
    Liu, Yuling
    Qu, Changhai
    Ni, Jian
    Li, Hui
    [J]. LIVER CANCER, 2020, 9 (05) : 563 - 582
  • [5] Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019
    Guiying Cao
    Jue Liu
    Min Liu
    [J]. Journal of Epidemiology and Global Health, 2023, 13 (2) : 344 - 360
  • [6] Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019
    Cao, Guiying
    Liu, Jue
    Liu, Min
    [J]. JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2023, 13 (02) : 344 - 360
  • [7] The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels
    Yang, Jianqing
    Pan, Guangdong
    Guan, Linjing
    Liu, Zhipeng
    Wu, Yongrong
    Liu, Zhen
    Lu, Wuchang
    Li, Shuai
    Xu, Honglai
    Ouyang, Guoqing
    [J]. CANCER MEDICINE, 2022, 11 (05): : 1357 - 1370
  • [8] The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
    Akinyemiju, Tomi
    Abera, Semaw
    Ahmed, Muktar
    Alam, Noore
    Alemayohu, Mulubirhan Assefa
    Allen, Christine
    Al-Raddadi, Rajaa
    Alvis-Guzman, Nelson
    Amoako, Yaw
    Artaman, Al
    Ayele, Tadesse Awoke
    Barac, Aleksandra
    Bensenor, Isabela
    Berhane, Adugnaw
    Bhutta, Zulfiqar
    Castillo-Rivas, Jacqueline
    Chitheer, Abdulaal
    Choi, Jee-Young
    Cowie, Benjamin
    Dandona, Lalit
    Dandona, Rakhi
    Dey, Subhojit
    Dicker, Daniel
    Phuc, Huyen
    Ekwueme, Donatus U.
    Zaki, Maysaa El Sayed
    Fischer, Florian
    Furst, Thomas
    Hancock, Jamie
    Hay, Simon I.
    Hotez, Peter
    Jee, Sun Ha
    Kasaeian, Amir
    Khader, Yousef
    Khang, Young-Ho
    Kumar, G. Anil
    Kutz, Michael
    Larson, Heidi
    Lopez, Alan
    Lunevicius, Raimundas
    Malekzadeh, Reza
    McAlinden, Colm
    Meier, Toni
    Mendoza, Walter
    Mokdad, Ali
    Moradi-Lakeh, Maziar
    Nagel, Gabriele
    Nguyen, Quyen
    Nguyen, Grant
    Ogbo, Felix
    [J]. JAMA ONCOLOGY, 2017, 3 (12) : 1683 - 1691
  • [9] The global burden of primary liver cancer and underlying etiologies from 1990 to 2021
    Kocarnik, Jonathan M.
    May, Miranda
    Acheson, Alistair
    Bhangdia, Kayleigh
    Compton, Kelly
    Dean, Frances
    Fu, Weijia
    Penberthy, Louise
    Pritchett, Natalie
    Xu, Rixing
    Bhakta, Nickhill
    Force, Lisa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019
    Liu, Yuan
    Zheng, Jinxin
    Hao, Jialing
    Wang, Rang Rang
    Liu, Xueni
    Gu, Peng
    Yu, Hongwei
    Yu, Yang
    Wu, Chuanxing
    Ou, Baochi
    Peng, Zhihai
    [J]. CANCER MEDICINE, 2022, 11 (05): : 1310 - 1323